Catalyst Wire Dossier Catalyst Wire Dossier

BC-3781 (14C-labeled)

· Nabriva Therapeutics AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BC-3781 (14C-labeled), covering 2018-04-03 to 2018-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781 [Phase 1]

See pricing